2016
DOI: 10.1038/nmat4644
|View full text |Cite
|
Sign up to set email alerts
|

Biomimetic proteolipid vesicles for targeting inflamed tissues

Abstract: A multitude of micro- and nanoparticles have been developed to improve the delivery of systemically administered pharmaceuticals, which are subject to a number of biological barriers that limit their optimal biodistribution. Bioinspired drug-delivery carriers formulated by bottom-up or top-down strategies have emerged as an alternative approach to evade the mononuclear phagocytic system and facilitate the transport across the endothelial vessel wall. Here, we describe a method that leverages the advantages of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
349
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 350 publications
(365 citation statements)
references
References 52 publications
10
349
0
Order By: Relevance
“…Other than stem cells, endothelial cells and white blood cells have also been employed to create nanodelivery vesicles capable of unique functions [148,149]. In a recent example, the proteins derived from the plasma membrane of leukocytes were mixed with synthetic lipids, and the resulting leukosomes were able to deliver dexamethasone to treat inflamed vasculature [150]. …”
Section: Cell Membrane-based Nanostructuresmentioning
confidence: 99%
“…Other than stem cells, endothelial cells and white blood cells have also been employed to create nanodelivery vesicles capable of unique functions [148,149]. In a recent example, the proteins derived from the plasma membrane of leukocytes were mixed with synthetic lipids, and the resulting leukosomes were able to deliver dexamethasone to treat inflamed vasculature [150]. …”
Section: Cell Membrane-based Nanostructuresmentioning
confidence: 99%
“…[156] Another example for a bioinspired particle coating to overcome biological barriers and improve biodistribution is proteolipid vesicles (i.e., 'leukosomes') to target inflamed tissue. [157] Stealth particles with low protein binding not only improved blood circulation and biodistribution, but retained targeting ability in the presence of complex biological environments.…”
Section: Reducing Protein Adsorptionmentioning
confidence: 99%
“…For example, surface proteins from leukocyte plasma membrane were extracted, and then the proteins were incorporated onto the liposome surface (58). The vesicles, so-called leukosomes displayed targeting ability to inflamed endothelia, and retained physicochemical properties of liposomes.…”
Section: Targeting Inflamed Endotheliummentioning
confidence: 99%